Literature DB >> 23062156

Diagnosis and treatment of acne.

Stephen Titus1, Joshua Hodge.   

Abstract

Acne is a chronic inflammatory skin disease that is the most common skin disorder in the United States. Therapy targets the four factors responsible for lesion formation: increased sebum production, hyperkeratinization, colonization by Propionibacterium acnes, and the resultant inflammatory reaction. Treatment goals include scar prevention, reduction of psychological morbidity, and resolution of lesions. Grading acne based on lesion type and severity can help guide treatment. Topical retinoids are effective in treating inflammatory and noninflammatory lesions by preventing comedones, reducing existing comedones, and targeting inflammation. Benzoyl peroxide is an over-the-counter bactericidal agent that does not lead to bacterial resistance. Topical and oral antibiotics are effective as monotherapy, but are more effective when combined with topical retinoids. The addition of benzoyl peroxide to antibiotic therapy reduces the risk of bacterial resistance. Oral isotretinoin is approved for the treatment of severe recalcitrant acne and can be safely administered using the iPLEDGE program. After treatment goals are reached, maintenance therapy should be initiated. There is insufficient evidence to recommend the use of laser and light therapies. Referral to a dermatologist should be considered if treatment goals are not met.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23062156

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  18 in total

1.  Severe Nodulocystic Acne not Responding to Isotretinoin Therapy Successfully Treated with Oral Dapsone.

Authors:  Lutfi Al-Kathiri; Tasneem Al-Najjar
Journal:  Oman Med J       Date:  2018-09

Review 2.  New Formulations of Isotretinoin for Acne Treatment: Expanded Options and Clinical Implications.

Authors:  Risha Bellomo; Matthew Brunner; Ella Tadjally
Journal:  J Clin Aesthet Dermatol       Date:  2021-12

3.  The investigation of the efficacy and safety of stromal vascular fraction in the treatment of nanofat-treated acne scar: a randomized blinded controlled clinical trial.

Authors:  Elham Behrangi; Sepideh Moradi; Mohammadreza Ghassemi; Azadeh Goodarzi; Amirreza Hanifnia; Sona Zare; Maryam Nouri; Abbas Dehghani; Azadeh Seifadini; Mohammad Ali Nilforoushzadeh; Masoumeh Roohaninasab
Journal:  Stem Cell Res Ther       Date:  2022-07-15       Impact factor: 8.079

4.  Comparison of topical 5% nicotinamid gel versus 2% clindamycin gel in the treatment of the mild-moderate acne vulgaris: A double-blinded randomized clinical trial.

Authors:  Zabiolah Shahmoradi; Farib Iraji; Amir Hossein Siadat; Azamosadat Ghorbaini
Journal:  J Res Med Sci       Date:  2013-02       Impact factor: 1.852

5.  Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne.

Authors:  Haibo Liu; Haiyan Yu; Jun Xia; Ling Liu; Guan J Liu; Hong Sang; Frank Peinemann
Journal:  Cochrane Database Syst Rev       Date:  2020-05-01

Review 6.  Insulin resistance and skin diseases.

Authors:  Maddalena Napolitano; Matteo Megna; Giuseppe Monfrecola
Journal:  ScientificWorldJournal       Date:  2015-04-21

7.  Efficacy of a twice-daily, 3-step, over-the-counter skincare regimen for the treatment of acne vulgaris.

Authors:  Katie Rodan; Kathy Fields; Timothy J Falla
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-01-04

8.  An Overview of Biofield Devices.

Authors:  David Muehsam; Gaétan Chevalier; Tiffany Barsotti; Blake T Gurfein
Journal:  Glob Adv Health Med       Date:  2015-11-01

9.  Evaluation of biophysical skin parameters and assessment of hair growth in patients with acne treated with isotretinoin.

Authors:  Małgorzata L Kmieć; Anna Pajor; Grażyna Broniarczyk-Dyła
Journal:  Postepy Dermatol Alergol       Date:  2013-12-18       Impact factor: 1.837

Review 10.  Topical PDT in the Treatment of Benign Skin Diseases: Principles and New Applications.

Authors:  Miri Kim; Haw Young Jung; Hyun Jeong Park
Journal:  Int J Mol Sci       Date:  2015-09-25       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.